Carry epinephrine - everywhere life takes you. Watch FARE’s PSA, “Ready to Live”

FARE - Food Allergy Research & Education Logo

Media Room

Releases & Statements

From advocacy to action, FARE moves from urging Uber to change its Super Bowl ad last year to debuting its own PSA; Demonstrates how to use humor without diminishing the experiences of patients, caregivers, and families

NY Governor Signs Law Requiring Health Insurance Coverage of Epinephrine Autoinjectors; Caps the Cost at $100

Grant to Increase Awareness Among Public Health Professionals, Primary Care Clinicians, and the Public

Report funded by the CDC, in partnership with the American Academy of Pediatrics; New resource complements guidelines introduced more than 10 years ago

New Guidance Benefits More than 713,000 Food Allergy Families; Updates 15-Year-Old Law

Partnership to Bring the FARE Neighborhoods Initiative to Kansas City, Offer Food Allergy Academy Training for Kansas City-Area Restaurants

Bakery doubles down on decision to add sesame in lieu of taking steps to prevent cross-contamination

For the third year, CVS Pharmacy is offering 60+ allergy-friendly treats in stores and online

Genentech announced as the event’s premier sponsor

HB 274 to Reverse the Rise of Food Allergies in the First State


Media Contact: 

media@foodallergy.org.
 


About FARE (Food Allergy Research & Education)

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—research, education, and advocacy. FARE's initiatives strive for a future free from food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. To learn more, visit FoodAllergy.org.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.